DSP Mutual Fund · #145454
DSP Healthcare Fund - Direct Plan - Growth
Equity · Sectoral/ Thematic · Direct · Growth
Direct TER: 0.75% · as of
5-year NAV · change the window using the controls in the rolling-returns card below ↓
2021-10-25 → 2026-10-21
Latest NAV
₹48.3460
as of 2026-10-21 · -0.01% vs 2026-10-19
Earliest NAV in archive
2018-12-03
AMFI archive begins Apr 2006
Trailing CAGR vs assigned benchmark
| Window | Scheme CAGR | Benchmark CAGR | Excess | Period |
|---|---|---|---|---|
| 1y | +9.58% | — | — | 2025-10-23 → today · 1.0y |
| 3y | +19.84% | — | — | 2023-10-23 → today · 3.0y |
| 5y | +15.28% | — | — | 2021-10-22 → today · 5.0y |
Benchmark assignment is mapped by category and sub-category from public sources. "Since inception (in archive)" uses the earliest NAV in the AMFI archive (April 2006 onward).
Rolling 1-year returns distribution · 1196 daily entry points · last 5 years
Imagine buying this fund on any day in this period and holding for exactly one year. Each bar counts how often that ended with a given return: green bars made money, red bars lost money even after a full year. Taller bar = more common outcome.
Median 1y return
+14.6%
Mean 1y return
+17.7%
Best / worst 1y
+62.4% / -14.0%
Windows positive
74%
Longer rolling windows · annualised
Same idea over longer holding periods. Returns are CAGR (annualised) so they're directly comparable to the trailing-CAGR table above.
| Period | Median | Mean | Worst | Best | % positive | Windows |
|---|---|---|---|---|---|---|
| 3y rolling | +22.8% | +23.7% | +15.0% | +35.1% | 100% | 1171 |
| 5y rolling | +25.3% | +24.0% | +14.2% | +35.4% | 100% | 677 |
Beat-benchmark consistency · vs assigned benchmark, across overlapping windows
Of all the rolling windows we observed, how often did this fund's return exceed the benchmark's over the same window. A higher fraction means more consistent outperformance, but says nothing about future windows.
| Period | Windows beat | Total windows | % beat | Avg excess (annualised) |
|---|---|---|---|---|
| 1y rolling | 335 | 562 | 60% | +0.6% |
| 3y rolling | 88 | 88 | 100% | +1.6% |
Monthly returns · since inception (Dec 2018)
How each calendar month went: green months gained, red months lost. Deeper colour = bigger move.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -4.8 | +2.3 | -5.0 | +7.8 | +5.0 | +5.7 | +2.4 | +4.8 | -3.3 | -3.3 | · | · | +11.1 |
| 2025 | -5.7 | -7.9 | +3.7 | -0.6 | +2.0 | +3.2 | +3.5 | -3.0 | -1.3 | +2.2 | +2.0 | -1.9 | -4.6 |
| 2024 | +5.3 | +5.0 | +0.5 | -0.6 | -1.9 | +4.7 | +12.1 | +5.5 | +3.8 | -0.1 | +1.9 | +0.5 | +42.6 |
| 2023 | -1.9 | -3.0 | +0.6 | +3.0 | +3.1 | +8.3 | +8.1 | +0.0 | +1.7 | -2.0 | +10.5 | +4.3 | +36.8 |
| 2022 | -7.5 | -3.0 | +2.9 | -1.0 | -6.6 | -4.5 | +7.1 | -1.1 | +3.3 | +3.8 | +3.7 | -2.9 | -6.5 |
| 2021 | -2.5 | +0.5 | +1.8 | +7.3 | +2.1 | +3.6 | +3.6 | +6.3 | -2.1 | -3.2 | +1.3 | +4.3 | +25.1 |
| 2020 | +8.1 | +1.2 | -8.7 | +17.5 | +3.1 | +4.6 | +12.9 | +5.9 | +8.1 | -0.9 | +5.0 | +5.8 | +80.0 |
| 2019 | +0.0 | -1.2 | +4.8 | -0.5 | -3.4 | -1.8 | +1.5 | +0.9 | -0.9 | +6.5 | +3.0 | +0.8 | +9.6 |
| Avg | -1.1 | -0.8 | +0.1 | +4.1 | +0.4 | +3.0 | +6.4 | +2.4 | +1.2 | +0.9 | +3.9 | +1.6 | +26.1 |
All values in %. Each cell compares the last NAV of the month with the last NAV of the month before. The latest month is month-to-date; the Year column compounds the months shown on that row. The Avg row is the plain average of each column across the years shown (7 complete calendar years in the last column); the running month is left out of it.
Portfolio mix · asset class breakdown as of 2026-09-30
Size axis (Style Box) · Large / Mid / Small split of latest disclosed holdings
Per AMFI's semi-annual Categorisation of Stocks (top 100 = Large, 101-250 = Mid, 251+ = Small).
- Large Cap 29.6%
- Mid Cap 16.9%
- Small Cap 51.3%
- Unlisted & other equity 2.2%
Index overlap
· vs · share of this fund's AUM that sits in stocks the index also includesNo holdings data yet for this fund.
Top stocks held · 27 holdings as of 2026-09-30 See changes vs previous snapshot →
| Stock | Sector | % of fund |
|---|---|---|
| IPCA Laboratories Limited | Pharmaceuticals & Biotechnology | 8.13% |
| Sun Pharmaceutical Industries Limited | Pharmaceuticals & Biotechnology | 7.44% |
| Cipla Limited | Pharmaceuticals & Biotechnology | 7.18% |
| Sai Life Sciences Limited | Pharmaceuticals & Biotechnology | 6.52% |
| Gland Pharma Limited | Pharmaceuticals & Biotechnology | 6.15% |
| Apollo Hospitals Enterprise Limited | Healthcare Services | 6.07% |
| Alkem Laboratories Limited | Pharmaceuticals & Biotechnology | 4.75% |
| Divi's Laboratories Limited | Pharmaceuticals & Biotechnology | 4.17% |
| Cohance Lifesciences Limited | Pharmaceuticals & Biotechnology | 3.79% |
| Alembic Pharmaceuticals Limited | Pharmaceuticals & Biotechnology | 3.18% |
| Kovai Medical Center And Hospital Limited | Healthcare Services | 2.83% |
| Pfizer Limited | Pharmaceuticals & Biotechnology | 2.72% |
| Concord Biotech Limited | Pharmaceuticals & Biotechnology | 2.70% |
| Vijaya Diagnostic Centre Limited | Healthcare Services | 2.36% |
| Procter & Gamble Health Limited | Pharmaceuticals & Biotechnology | 2.36% |
| Indoco Remedies Limited | N.A. | 2.26% |
| Thyrocare Technologies Limited | Healthcare Services | 1.91% |
| Manipal Health Enterprises Limited | Healthcare Services | 1.85% |
| Unichem Laboratories Limited | Pharmaceuticals & Biotechnology | 1.64% |
| Syngene International Limited | Healthcare Services | 1.35% |
Sector mix
- Healthcare 96.1%
- N.A. 2.7%
- Financial Services 1.2%
Risk metrics, trailing 3y (700 matched daily returns, 2023-10-25 → 2026-10-21)
Calmar
+1.23
CAGR / |max DD| in window
Risk-free rate assumed 6.0% annualised. Benchmark = Nifty Healthcare Index (assigned by category mapping).
Factual data only. No investment advice or recommendation. Read the scheme document and consult a SEBI-registered Investment Adviser for personalised guidance.